Clinical Evaluation of MJD-1741 for Herpes Simplex

Keyphrases

• Clinical Evaluation 100%
• Herpes Simplex 100%
• Herpes Simplex Virus Infection 50%
• Buttocks 50%
• Clinical Efficacy 50%
• Clinical Safety 50%
• Ointment 50%
• Herpes 50%
• Herpes Labialis 50%
• Vidarabine 50%
• Kaposi Varicelliform Eruption 50%
• Herpes Genitalis 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Herpes Simplex 100%
• Side Effect 50%
• Infection 50%
• Virus Infection 50%
• Genital Herpes 50%
• Herpes Simplex Virus 50%
• Herpes Labialis 50%
• Vidarabine 50%
• Kaposi Varicelliform Eruption 50%